Protected intake, payment, prescribing, and care enrollment reopen in September.

Collagen Peptides After Menopause: Do They Work?

Jun 30, 2026 · 9 min readRolf Hoefer, Ph.D.

9 sources reviewedMedically reviewed by Amy Bingaman, MD, MSCP, FACOGArticle updated Jul 3, 2026Our editorial process

The short answer

Collagen peptides have more skin-aging evidence than many peptide trends, but they still deserve a cautious supplement-level claim. A 2023 meta-analysis of 26 randomized trials and 1,721 participants found improved skin hydration and elasticity versus placebo. A 2025 meta-analysis of 23 trials and 1,474 participants found apparent benefits overall, but no effect in studies without pharmaceutical-company funding and no significant effect in high-quality studies. Collagen peptides can be discussed as a modest, product-specific adjunct, not as menopause skin reversal, hormone therapy, or a replacement for sunscreen, retinoids, pigment diagnosis, barrier care, or dermatology review. [2]

What you’ll learn

  • Collagen peptides have randomized-trial data for hydration and elasticity signals, but the evidence is not a clean menopause skin-reversal story.
  • The 2025 meta-analysis is the most important caution signal: benefits disappeared in unfunded studies and in high-quality studies.
  • Product specificity matters. Trials use defined sources, doses, durations, and endpoints; results do not automatically transfer to every powder, gummy, capsule, creamer, or peptide blend.
  • FDA does not approve dietary supplements before marketing, so product claims, dose transparency, allergens, third-party testing, and medication or disease context need separate review.

Collagen peptides are one of the few "beauty peptide" categories with real randomized skin studies.

That does not make them a menopause skin reversal treatment.

A 2023 systematic review and meta-analysis included 26 randomized controlled trials with 1,721 participants. Hydrolyzed collagen supplementation significantly improved skin hydration and elasticity versus placebo, while the authors also noted biases in the included trials and called for larger randomized trials. [2]

That supports discussion.

It does not support treating collagen powder as a substitute for sunscreen, retinoids, diagnosis of pigment, or evaluation of changing lesions.

The evidence is limited by product heterogeneity, short trials, industry involvement, variable outcomes, and the lack of dedicated postmenopause skin-reversal trials.

The most important collagen caveat is study quality

The strongest-looking results are not the whole story.

A 2025 systematic review and meta-analysis examined 23 randomized trials with 1,474 participants. Across all trials, collagen supplements appeared to improve hydration, elasticity, and wrinkles. [3]

Then the subgroup analysis changed the interpretation.

Studies without pharmaceutical-company funding showed no effect for hydration, elasticity, or wrinkles. High-quality studies also showed no significant effect across those categories. Lower-quality studies showed an elasticity signal. The authors concluded that there was no clinical evidence to support collagen supplements to prevent or treat skin aging. [3]

That does not establish every collagen product is useless.

It means the honest answer is narrower: collagen peptides may produce modest cosmetic signals in some product-specific trials, but the claim is fragile when funding and quality are separated.

Article table: Evidence question, What supports discussion, What limits the claim
Evidence questionWhat supports discussionWhat limits the claim
HydrationThe 2023 meta-analysis found a hydration benefit across 26 trials. [2]The 2025 review found no hydration effect in unfunded or high-quality studies. [3]
ElasticitySeveral pooled analyses and trials report elasticity signals. [2] [4]Product, dose, population, quality, and funding change confidence.
WrinklesThe 2025 review found overall wrinkle improvement across all included trials. [3]That signal disappeared in high-quality and unfunded analyses. [3]
Menopause-specific skin reversalSome trials include midlife women, and one bone trial studied postmenopausal women. [4] [6]Skin trials are not built as menopause-reversal trials.
SafetyReviews report generally few adverse events in trials. [5]Supplements still require allergy, ingredient, dose, and disease-context review.

The better page does not ask, "Do collagen peptides work?" It asks, "What claim survives the quality caveat?"

Product-specific trial evidence does not cover every tub of powder

One commonly cited double-blind trial randomized 69 women aged 35 to 55 to 2.5 g collagen hydrolysate, 5.0 g collagen hydrolysate, or placebo once daily for 8 weeks. Skin elasticity improved in both collagen groups compared with placebo. Skin moisture and skin evaporation showed positive subgroup signals but did not reach statistical significance overall. No side effects were noted during the study. [4]

That trial gives a real dose, duration, endpoint, and population.

It does not establish that every collagen gummy, coffee creamer, capsule, powder, marine blend, bovine blend, or "beauty peptide" stack produces the same result.

Another randomized trial in 99 healthy Japanese women aged 35 to 50 tested 1 g or 5 g collagen peptides or placebo for 12 weeks. Collagen peptides increased stratum corneum and epidermal water content and decreased transepidermal water loss, while elasticity and skin thickness did not change. [7]

That is a useful reminder: even positive trials may move hydration while not moving every anti-aging endpoint.

Peptides are not one evidence category

A 2026 systematic review and meta-analysis looked more broadly at oral and topical peptides for skin aging. It included 19 randomized trials with 1,341 participants. Peptides, especially oral formulations, improved hydration and brightness; wrinkle reduction had a modest pooled effect, and effects on elasticity and density were inconsistent. The authors called for larger randomized trials with standardized outcomes and histopathologic assessment. [1]

That broader peptide review is helpful for context, but it should not be used to blur categories.

Oral collagen peptides, topical signal peptides, copper peptides, injectable peptide protocols, fillers, microneedling, laser, and prescription retinoids are different evidence questions.

Article table: Product category, Better question
Product categoryBetter question
Oral collagen peptidesIs there human trial evidence for this source, dose, duration, and skin endpoint?
Topical cosmetic peptidesIs there product-specific human evidence, or only ingredient/mechanism logic?
Injectable peptide protocolsIs there approved-drug evidence, safety monitoring, and a legitimate indication?
Retinoids or tretinoinIs photoaging, acne, or pigment the main target, and can irritation be managed?
ProceduresIs the concern laxity, volume, texture, pigment, scars, or wrinkles, and what is the risk profile?

Using one peptide category to justify another is how supplement claims become sloppy.

FDA supplement rules change how product claims should be read

Collagen peptides sold as dietary supplements are regulated differently from drugs.

FDA says dietary supplement manufacturers and distributors are responsible for evaluating safety and labeling before marketing, and FDA can act against adulterated or misbranded supplements after they reach the market. [8]

FDA also says it does not have authority to approve dietary supplements before they are marketed, generally does not approve supplement claims before use, and does not test supplements before they are sold to consumers. [9]

That is why a product decision should look beyond the headline trial.

Article table: Product question, Why it matters
Product questionWhy it matters
Does the label disclose source and dose?Marine, bovine, porcine, chicken, or mixed sources may matter for allergies, diet, and trial matching.
Is the studied dose close to the product dose?Trial results should not be stretched to vague "proprietary blend" amounts.
Is there third-party testing?Supplements are not FDA-approved before marketing, so identity and purity signals matter.
Are there added actives?Biotin, herbs, vitamins, sweeteners, caffeine, or hormone-adjacent ingredients change the safety review.
Is the claim cosmetic or medical?Treating disease, healing wounds, reversing menopause, or replacing osteoporosis care is a different claim.
Is there a safety reason to ask first?Allergies, kidney disease, protein restriction, pregnancy possibility, anticoagulants, and complex supplement stacks can change the risk discussion.

The issue is not that collagen is uniquely risky. The issue is that supplement labels are not equivalent to prescription evidence.

Menopause skin is more than collagen intake

After menopause, skin may feel drier, thinner, slower to recover, and more reactive. Wrinkles, laxity, pigment change, acne, rosacea, itching, and actinic damage can overlap.

Collagen peptides may fit a low-risk supplement discussion for some women who understand the evidence limits and can afford a time-limited trial.

They should not displace interventions with clearer skin-aging logic: daily sunscreen, smoking avoidance, barrier repair, retinoid planning when tolerated, pigment diagnosis, actinic keratosis or skin-cancer evaluation, and realistic procedure counseling.

A separate 12-month randomized trial studied 5 g of specific collagen peptides for bone mineral density in postmenopausal women with primary age-related bone-density reduction. One hundred two women completed the study, and the specific collagen peptide group had improved spine and femoral-neck bone mineral density measures compared with placebo. [6]

That is real postmenopause evidence.

It is also a bone endpoint. It should not be repurposed into a facial-wrinkle promise.

Who collagen peptides fit

Collagen peptides may fit someone looking for a modest oral supplement trial for skin hydration or elasticity, especially if she understands that benefit is uncertain, product-specific, and less evidence-backed than photoprotection or prescription photoaging treatment.

They may also fit someone who wants a low-complexity adjunct and is not using the supplement to avoid diagnosis of rash, pigment, hair loss, osteoporosis, or systemic symptoms.

They are a weaker fit when the main concern is a changing lesion, severe dryness or itching, new rash, melasma, acne, rosacea, rapid skin change, unexplained bruising, or the need for osteoporosis prevention or treatment.

Who should avoid or pause

Pause before starting collagen peptides if there is a known allergy to the source ingredient, kidney disease, medically directed protein restriction, complex supplement stacking, pregnancy possibility, active cancer treatment, anticoagulant use with other supplement ingredients, or any product that hides the collagen dose behind a proprietary blend.

Also pause if the skin concern is actually a red flag: bleeding, nonhealing, rapidly changing, painful, scaly, asymmetric, or pigmented lesions should be checked before being framed as "collagen loss."

What to ask a clinician

Ask:

  1. Is my main goal hydration, barrier comfort, wrinkles, pigment, acne, rosacea, hair, bone health, or a changing lesion?
  2. Which collagen source, dose, duration, and study endpoint match the claim I am considering?
  3. Does this product have third-party testing, transparent dosing, and an ingredient list that fits my allergy and medication context?
  4. Are there reasons to prioritize sunscreen, retinoids, moisturizers, pigment care, menopause symptom care, bone-density screening, or procedure review instead?
  5. What outcome would be realistic to measure after 8 to 12 weeks, and what would count as no meaningful benefit?
  6. Am I using this supplement as an adjunct, or to avoid a diagnosis that should happen first?

A structured skin assessment can separate dryness, photoaging, pigment, acne, rosacea, actinic damage, barrier injury, and changing lesions before a supplement claim becomes the whole plan.

Bottom line

Collagen peptides may be a reasonable adjunct for someone who understands the limits.

They are not hormone therapy, not tretinoin, not sunscreen, not osteoporosis treatment, and not evidence that a peptide product reverses menopause skin aging.

The most responsible claim is modest: some randomized trials and meta-analyses show hydration and elasticity signals, but product specificity, trial quality, funding, and menopause-specific limits matter.

Related reading:

References

[1] Nukaly HY, Halawani IR, Irtaza HM, et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306. doi:10.3389/fmed.2026.1618306 https://pubmed.ncbi.nlm.nih.gov/41924746/

[2] Pu SY, Huang YL, Pu CM, et al. Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(9). doi:10.3390/nu15092080 https://pubmed.ncbi.nlm.nih.gov/37432180/

[3] Myung SK, Park Y. Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Med. 2025;138(9):1264-1277. doi:10.1016/j.amjmed.2025.04.034 https://pubmed.ncbi.nlm.nih.gov/40324552/

[4] Proksch E, Segger D, Degwert J, Schunck M, Zague V, Oesser S. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55. doi:10.1159/000351376 https://pubmed.ncbi.nlm.nih.gov/23949208/

[5] Choi FD, Sung CT, Juhasz ML, Mesinkovsk NA. Oral Collagen Supplementation: A Systematic Review of Dermatological Applications. J Drugs Dermatol. 2019;18(1):9-16. https://pubmed.ncbi.nlm.nih.gov/30681787/

[6] König D, Oesser S, Scharla S, Zdzieblik D, Gollhofer A. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018;10(1). doi:10.3390/nu10010097 https://pubmed.ncbi.nlm.nih.gov/29337906/

[7] Miyanaga M, Uchiyama T, Motoyama A, Ochiai N, Ueda O, Ogo M. Oral Supplementation of Collagen Peptides Improves Skin Hydration by Increasing the Natural Moisturizing Factor Content in the Stratum Corneum: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Skin Pharmacol Physiol. 2021;34(3):115-127. doi:10.1159/000513988 https://pubmed.ncbi.nlm.nih.gov/33774639/

[8] U.S. Food and Drug Administration. Dietary Supplements. https://www.fda.gov/food/dietary-supplements

[9] U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements

Common questions

Do collagen peptides help menopause skin?

They may help hydration or elasticity in some trials, but menopause-specific evidence is limited. A 2023 review included 26 randomized trials with 1,721 people, not a dedicated postmenopause skin-reversal program.[2]

Why are collagen results controversial?

A 2025 review of 23 randomized trials and 1,474 participants found benefits overall, but not in unfunded studies or high-quality studies. That weakens broad anti-aging claims.[3]

What dose has been studied?

One double-blind trial randomized 69 women aged 35 to 55 to 2.5 g, 5.0 g, or placebo daily for 8 weeks. That is product-specific evidence, not evidence for every collagen product.[4]

Can collagen replace retinoids or sunscreen?

No. Collagen peptide trials are oral-supplement evidence for selected skin endpoints, not evidence that collagen replaces photoprotection, retinoid planning, pigment diagnosis, barrier repair, or clinician review for changing lesions.[2][3][8][9]